Ramiro Castro‐Santamaria

1.2k total citations
40 papers, 882 citations indexed

About

Ramiro Castro‐Santamaria is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Urology. According to data from OpenAlex, Ramiro Castro‐Santamaria has authored 40 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 9 papers in Urology. Recurrent topics in Ramiro Castro‐Santamaria's work include Prostate Cancer Diagnosis and Treatment (27 papers), Prostate Cancer Treatment and Research (24 papers) and Cancer, Lipids, and Metabolism (9 papers). Ramiro Castro‐Santamaria is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (27 papers), Prostate Cancer Treatment and Research (24 papers) and Cancer, Lipids, and Metabolism (9 papers). Ramiro Castro‐Santamaria collaborates with scholars based in United States, Canada and United Kingdom. Ramiro Castro‐Santamaria's co-authors include Daniel M. Moreira, Stephen J. Freedland, Gerald L. Andriole, Lauren E. Howard, Adriana C. Vidal, J. Curtis Nickel, Leah Gerber, Roberto L. Müller, Claus G. Roehrborn and Emma H. Allott and has published in prestigious journals such as Cancer, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Ramiro Castro‐Santamaria

39 papers receiving 872 citations

Peers

Ramiro Castro‐Santamaria

PRM

ONCOL

EDM

Gianna Mariotti Italy

C. Avancès France

Zhao-Dian Chen China

Zhaowei Zhu China

M. Luján Spain

Rolf-Hermann Ringert Germany

K. Gary Barnette United States

Baoxing Liu China

Lijiang Sun China

Peter McArdle United Kingdom

Gianna Mariotti Italy

Ramiro Castro‐Santamaria

525 ×1.0

PRM

60 ×0.3

114 ×0.5

ONCOL

153 ×0.8

143 ×0.9

EDM

Citations per year, relative to Ramiro Castro‐Santamaria Ramiro Castro‐Santamaria (= 1×) peers Gianna Mariotti

Countries citing papers authored by Ramiro Castro‐Santamaria

Since Specialization

Citations

This map shows the geographic impact of Ramiro Castro‐Santamaria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramiro Castro‐Santamaria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramiro Castro‐Santamaria more than expected).

Fields of papers citing papers by Ramiro Castro‐Santamaria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramiro Castro‐Santamaria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramiro Castro‐Santamaria. The network helps show where Ramiro Castro‐Santamaria may publish in the future.

Co-authorship network of co-authors of Ramiro Castro‐Santamaria

This figure shows the co-authorship network connecting the top 25 collaborators of Ramiro Castro‐Santamaria. A scholar is included among the top collaborators of Ramiro Castro‐Santamaria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramiro Castro‐Santamaria. Ramiro Castro‐Santamaria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crim, Courtney, Mark H. Gotfried, Selwyn Spangenthal, et al.. (2020). A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD. BMC Pulmonary Medicine. 20(1). 119–119. 9 indexed citations

Crim, Courtney, Michael L. Watkins, Eric Bateman, et al.. (2019). <p>Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD</p>. International Journal of COPD. Volume 14. 615–629. 6 indexed citations

Patel, Devin, Tom Feng, Lauren E. Howard, et al.. (2018). PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study. Prostate Cancer and Prostatic Diseases. 21(2). 238–244. 11 indexed citations

Nickel, J. Curtis, et al.. (2018). Both acute and chronic inflammation are associated with less perineural invasion in men with prostate cancer on repeat biopsy. British Journal of Urology. 123(1). 91–97. 10 indexed citations

Allott, Emma H., Lauren E. Howard, Adriana C. Vidal, et al.. (2017). Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial. Cancer Prevention Research. 10(6). 319–326. 21 indexed citations

Moreira, Daniel M., Gerald L. Andriole, Ramiro Castro‐Santamaria, & Stephen J. Freedland. (2017). Baseline prostate atrophy is associated with lower tumor volume in men with prostate cancer on repeat biopsy. Prostate Cancer and Prostatic Diseases. 21(1). 106–112. 2 indexed citations

Howard, Lauren E., Emma H. Allott, Daniel M. Moreira, et al.. (2017). Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study. Prostate Cancer and Prostatic Diseases. 21(2). 252–259. 71 indexed citations

Moreira, Daniel M., Gerald L. Andriole, J. Curtis Nickel, et al.. (2017). Dutasteride is associated with reduced risk of transrectal prostate biopsy-associated urinary tract infection and related hospitalizations. World Journal of Urology. 35(10). 1525–1530. 1 indexed citations

Andriole, Gerald L., et al.. (2016). Extent of Baseline Prostate Atrophy Is Associated With Lower Incidence of Low- and High-grade Prostate Cancer on Repeat Biopsy. Urology. 103. 161–166. 7 indexed citations

10.

Fischer, Stefanie, Shaomei Sun, Lauren E. Howard, et al.. (2016). Baseline subject characteristics predictive of compliance with study-mandated prostate biopsy in men at risk of prostate cancer: results from REDUCE. Prostate Cancer and Prostatic Diseases. 19(2). 202–208. 8 indexed citations

11.

Moreira, Daniel M., J. Curtis Nickel, Gerald L. Andriole, Ramiro Castro‐Santamaria, & Stephen J. Freedland. (2016). Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study. Prostate Cancer and Prostatic Diseases. 19(2). 180–184. 10 indexed citations

12.

Moreira, Daniel M., J. Curtis Nickel, Leah Gerber, et al.. (2015). Smoking Is Associated with Acute and Chronic Prostatic Inflammation: Results from the REDUCE Study. Cancer Prevention Research. 8(4). 312–317. 27 indexed citations

13.

Howard, Lauren E., Daniel M. Moreira, Claus G. Roehrborn, et al.. (2015). Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial. European Urology. 69(5). 885–891. 25 indexed citations

14.

Vidal, Adriana C., Lauren E. Howard, Daniel M. Moreira, et al.. (2015). MP60-09 DOES OBESITY MODIFY THE ABILITY OF PRE-BIOPSY PSA TO DETECT PROSTATE CANCER ON REPEAT BIOPSY? RESULTS FROM THE REDUCE STUDY. The Journal of Urology. 193(4S). 1 indexed citations

15.

Feng, Tom, Lauren E. Howard, Adriana C. Vidal, et al.. (2015). Metformin Use and Risk of Prostate Cancer: Results from the REDUCE Study. Cancer Prevention Research. 8(11). 1055–1060. 28 indexed citations

16.

Howard, Lauren E., Adriana C. Vidal, Leah Gerber, et al.. (2014). Smoking and Risk of Low- and High-Grade Prostate Cancer: Results from the REDUCE Study. Clinical Cancer Research. 20(20). 5331–5338. 26 indexed citations

17.

Vidal, Adriana C., Lauren E. Howard, Daniel M. Moreira, et al.. (2014). Aspirin, NSAIDs, and Risk of Prostate Cancer: Results from the REDUCE Study. Clinical Cancer Research. 21(4). 756–762. 88 indexed citations

18.

Moreira, Daniel M., J. Curtis Nickel, Leah Gerber, et al.. (2013). 1176 SMOKING IS ASSOCIATED WITH ACUTE PROSTATIC INFLAMMATION IN MEN WITH A NEGATIVE PROSTATE BIOPSY: RESULTS FROM THE REDUCE STUDY. The Journal of Urology. 189(4S). 3 indexed citations

19.

Müller, Roberto L., Leah Gerber, Daniel M. Moreira, et al.. (2012). Serum Testosterone and Dihydrotestosterone and Prostate Cancer Risk in the Placebo Arm of the Reduction by Dutasteride of Prostate Cancer Events Trial. European Urology. 62(5). 757–764. 105 indexed citations

20.

Gerber, Lukas C., Daniel M. Moreira, Robert J. Hamilton, et al.. (2011). Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1). Journal of Internal Medicine. 272(1). 85–92. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact